Lilly's Retevmo wins US nod for specific lung, thyroid cancers

12th May 2020 Uncategorised 0

The selective RET kinase inhibitor was cleared under the regulator’s accelerated approval process

More: Lilly's Retevmo wins US nod for specific lung, thyroid cancers
Source: News